Print Page   |   Contact Us   |   Sign In   |   Join Today
News & Press: Company News

HemoShear Names Vincent E. Aurentz as President

Wednesday, June 24, 2015  
Share |
HemoShear, recently named Vincent E. Aurentz, Chief Business Officer, as the new President of HemoShear. Mr. Aurentz will be responsible for leading HemoShear's scientific and business development strategies, as well as public relations and marketing, in addition to his existing business development responsibilities. He will continue to report directly to CEO and Chairman Jim Powers, and will also join HemoShear's Board of Managers.

"Vince joined HemoShear in July, 2013, and has been instrumental in the evolution of our business strategy", said Mr. Powers. "Importantly, he has led HemoShear's efforts to leverage our unique disease tissue models and scientific expertise to begin our own drug discovery programs that we believe will create tremendous value for all our stakeholders. I look forward to working closely with Vince as we implement HemoShear's vision to discover and develop drugs for patients who lack safe and effective treatments for metabolic, cardiovascular, inflammatory and rare diseases."

Mr. Aurentz's appointment will utilize his more than 25 years of experience in the pharmaceutical and biotech industry as an entrepreneur and pharmaceutical R&D executive. He spent almost nine years with Merck KGaA and Merck Serono where he was Executive Vice President, Portfolio Development and member of the Executive Management Board as well as Head of Global Business Development. He was also recently Executive Vice President at Quintiles.

"This is an exciting time at HemoShear as we expand our programs to include a major focus on drug discovery, applying our transformational platform, REVEAL-Tx™, to identify novel therapeutic targets and biomarkers," said Vince Aurentz. "I am pleased to be part of the leadership that will further drive the vision of our co-founders, Drs. Brett Blackman and Brian Wamhoff, to profoundly impact human health by delivering important therapeutics to patients with high unmet need."

more Events

10/26/2016 » 10/27/2016
UVA Fall Job & Internship Fair

Premium Members

Membership Software Powered by YourMembership  ::  Legal